ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2014

An economic analysis: is fidaxomicin worth the cost?

Hemal Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.